Patents by Inventor Patrick Ellison Sewell

Patrick Ellison Sewell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of age-related cognitive decline using genetically modified viral vectors
    Patent number: 12564646
    Abstract: Disclosed herein are methods for treating or prophylactically treating age-related cognitive decline associated with dementia by administering recombinant viral vectors designed to deliver TERT and/or KL (Klotho) genes to the patient. The TERT and/or KL genes are packaged within one or more AAV viral vectors and administered to the CNS of the patient via intranasal and/or intrathecal injection. The therapy can provide improvements in cognitive function as evidenced by improved Folstein/MMSE scores over time.
    Type: Grant
    Filed: June 15, 2022
    Date of Patent: March 3, 2026
    Assignee: BIOVIVA USA, INC.
    Inventors: Elizabeth Louise Parrish, Patrick Ellison Sewell, Jason R. Williams
  • TREATMENT OF AGE-RELATED COGNITIVE DECLINE USING GENETICALLY MODIFIED VIRAL VECTORS
    Publication number: 20220401583
    Abstract: Disclosed herein are methods for treating or prophylactically treating age-related cognitive decline associated with dementia by administering recombinant viral vectors designed to deliver TERT and/or KL (Klotho) genes to the patient. The TERT and/or KL genes are packaged within one or more AAV viral vectors and administered to the CNS of the patient via intranasal and/or intrathecal injection. The therapy can provide improvements in cognitive function as evidenced by improved Folstein/MMSE scores over time.
    Type: Application
    Filed: June 15, 2022
    Publication date: December 22, 2022
    Inventors: Elizabeth Louise Parrish, Patrick Ellison Sewell, Jason R. Williams